(3-氧代环己基)乙酸 | 39762-51-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (3-氧代环己基)乙酸
• 英文名称: (3-Oxo-cyclohexyl)-essigsaeure
• 英文别名: (3-Oxo-cyclohexyl)-acetic Acid；2-(3-oxocyclohexyl)acetic Acid
• CAS: 39762-51-1
• 化学式: C₈H₁₂O₃
• mdl: MFCD01529608
• 分子量: 156.181
• InChiKey: RYTWPAUCABOYJP-UHFFFAOYSA-N

物化性质

• 熔点：
  81-82 °C
• 沸点：
  327.5±15.0 °C(Predicted)
• 密度：
  1.155±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918300090

反应信息

• 作为反应物：
  描述：

  (3-氧代环己基)乙酸 在 盐酸 、 lithium hydroxide 、 sodium hydroxide 、 Bn₄NCl 、 1,1-二甲氧基丙烷 、 溶剂黄146 、 三乙胺 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 30.0h， 生成 N-(2',2'-dimethoxyethyl)-1,2,3,4-tetrahydro-4-oxo-9-<(p-methoxyphenyl)sulfonyl>carbazole-2-acetamide
  参考文献：
  名称：

  Studies on the synthesis of Strychnos alkaloids. A new entry into the azocino[4,3-b]indole core structure and related studies

  摘要：

  Treatment of cyclohexanone-3-acetic acid with phenylhydrazine hydrochloride gave the tetrahydrocarbazole 7 (73%). The derived methyl ester 8 (99.6%) was oxidized to the 4-oxo compound 9 in 85% yield by treatment with DDQ/90% aqueous THF at 0-degrees-C. Treatment of 9 with NaH/DMF at 0-degrees-C followed by (p-methoxyphenyl)sulfonyl chloride gave 10 (81%). Hydrolysis of 10 using lithium hydroxide in aqueous THF gave the acid 11 (86%). The acid 11 was converted into the amide 12 by treatment with ethylchloroformate/NEt3/CH2Cl2 followed by aqueous NH4OH. The ketoamide 12 was exposed to NaBH4/MeOH/THF to give a single alcohol 13 (> 95%). Exposure of 13 to trifluoroacetic acid (cat)/CH2Cl2/0-20-degrees-C gave the azocino[4.3-b]indole core tetracyclic lactam 14 (90%). The amide 14 was reduced (BH3.THF) to give 21, which was directly acetylated (PhSCH2COCl) to give exocyclic amide 22. All attempts to close the C11-C12 bond only resulted in decomposition. Treatment of the acid 11 with EtO2CCl/Et3N followed by [2-(phenylthio)ethyl]amine gave the amide 24 (90%). Reduction of 24 using NaBH4 gave the alcohol 25 which upon exposure to CF3CO2H at room temperature cyclized to the tetracyclic amide 26 (96% overall). Oxidation of the sulfide 26 (m-CPBA) resulted in the diastereomeric sulfoxides 28. When the sulfoxides 28 were exposed to Pummerer conditions the only products that could be isolated were the (E)- and (Z)-vinyl sulfides 29 (72% and 25%, respectively). Similarly the dimethylthio acetal 33 was converted into the aldehyde 34 (100%). Treatment of 26 with POCl3/DMF gave 35 (90.8%) which was exposed to PhNHNH2/AcOH/AcONa to give the pyrazole 36 (85%). Attempts to close the E-ring via sulfoxides derived from either the pyrazole 36 or the oxazole 37 were unsuccessful. Treatment of the chloride 40 with KH/HN(SiMe3)2 in toluene resulted in a slow conversion into the 3-oxindole 44.

  DOI：

  10.1021/jo00027a016
• 作为产物：
  描述：

  1,3-diethyl 2-(3-oxocyclohexyl)propanedioate 在 盐酸 作用下， 以 水 为溶剂， 生成 (3-氧代环己基)乙酸
  参考文献：
  名称：

  从β-酮羧酸轻松合成螺环内酰胺

  摘要：

  据报道，通过一锅级联反应，从Cu酮重排，并将烯醇碳分子内亲核加成到异氰酸酯中间体上，从β-酮羧酸容易地合成螺环内酰胺。相同的条件也已用于产生具有相似良好收率的稠合环状内酰胺。该方法的合成价值已通过有效合成四环螺内酰胺8和五环螺内酰胺9得以证明。

  DOI：

  10.1021/acs.orglett.5b01350

文献信息

• [EN] AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF<br/>[FR] COMPOSÉS AMIDES, COMPOSITIONS ET APPLICATIONS DE CEUX-CI
  申请人：ADVINUS THERAPEUTICS LTD

  公开号：WO2013042139A1

  公开（公告）日：2013-03-28

  The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them. These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Fatty Acid Amide Hydrolase (FAAH), such as pain including acute and post operative pain, chronic pain, cancer pain, cancer chemotherapy induced pain, neuropathic pain, nociceptive pain, inflammatory pain, back pain, pain due to disease of various origin such as: diabetic neuropathy, neurotropic viral disease including human immunodeficient virus (HIV), herpes zoster such as post herpetic neuralgia; polyneuropathy, neurotoxicity, mechanical nerve injury, carpal tunnel syndrome, immunologic mechanisms like multiple sclerosis; sleep disorders, anxiety and depression disorders, inflammatory disorders, weight and eating disorders, Parkinson's disease, addiction, spasticity, hypertension or other disorders. The disclosure also relates to the process of preparation of the amide compounds. Formula (1). The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.

  本公开涉及替代酰胺化合物，这些化合物是脂肪酸酰胺水解酶（FAAH）的抑制剂，包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶（FAAH）抑制相关的所有医疗状况中非常有用，例如疼痛，包括急性和术后疼痛，慢性疼痛，癌症疼痛，癌症化疗引起的疼痛，神经痛，伤害性疼痛，炎症性疼痛，背部疼痛，疾病引起的疼痛，如糖尿病性神经病变，神经病毒性疾病，包括人类免疫缺陷病毒（HIV），带状疱疹，如带状疱疹后神经痛；多发性神经病，神经毒性，机械神经损伤，腕管综合症，类似多发性硬化的免疫机制；睡眠障碍，焦虑和抑郁症，炎症性疾病，体重和进食障碍，帕金森病，成瘾，痉挛，高血压或其他疾病。该公开还涉及酰胺化合物的制备过程。公式（1）。本公开还涉及制备这类化合物的方法，以及含有它们的药物组合物。
• AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
  申请人：ADVINUS THERAPEUTICS LIMITED

  公开号：US20150065464A1

  公开（公告）日：2015-03-05

  The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them. These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Fatty Acid Amide Hydrolase (FAAH), such as pain including acute and post operative pain, chronic pain, cancer pain, cancer chemotherapy induced pain, neuropathic pain, nociceptive pain, inflammatory pain, back pain, pain due to disease of various origin such as: diabetic neuropathy, neurotropic viral disease including human immunodeficient virus (HIV), herpes zoster such as post herpetic neuralgia; polyneuropathy, neurotoxicity, mechanical nerve injury, carpal tunnel syndrome, immunologic mechanisms like multiple sclerosis; sleep disorders, anxiety and depression disorders, inflammatory disorders, weight and eating disorders, Parkinson's disease, addiction, spasticity, hypertension or other disorders. The disclosure also relates to the process of preparation of the amide compounds. The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.

  本公开涉及替代酰胺化合物，它们是脂肪酸酰胺水解酶（FAAH）的抑制剂，包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用可接受盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶（FAAH）抑制相关的所有医疗状况中非常有用，如疼痛，包括急性和术后疼痛，慢性疼痛，癌症疼痛，癌症化疗引起的疼痛，神经痛，伤害性疼痛，炎症性疼痛，背部疼痛，疾病引起的疼痛，如糖尿病性神经病变，神经病毒性疾病，包括人类免疫缺陷病毒（HIV），带状疱疹，如带状疱疹后神经痛；多发性神经病，神经毒性，机械神经损伤，腕管综合症，免疫机制如多发性硬化症；睡眠障碍，焦虑和抑郁症，炎症性疾病，体重和进食障碍，帕金森病，成瘾，痉挛，高血压或其他疾病。本公开还涉及酰胺化合物的制备过程。本公开还涉及制备这类化合物的方法，以及含有它们的药物组合物。
• [EN] TRIOXOLANE AGENTS<br/>[FR] AGENTS TRIOXOLANE
  申请人：UNIV CALIFORNIA

  公开号：WO2019005977A1

  公开（公告）日：2019-01-03

  Disclosed herein, inter alia, are trioxolane compounds and methods of using the same for treatment and detection of diseases.

  本文披露了三氧杂环戊烷化合物及其在治疗和检测疾病中的应用方法。
• Ultra-High-Throughput Acoustic Droplet Ejection-Open Port Interface-Mass Spectrometry for Parallel Medicinal Chemistry
  作者：Kenneth J. DiRico、Wenyi Hua、Chang Liu、Joseph W. Tucker、Anokha S. Ratnayake、Mark E. Flanagan、Matthew D. Troutman、Mark C. Noe、Hui Zhang

  DOI：10.1021/acsmedchemlett.0c00066

  日期：2020.6.11

  (HTE) has emerged as an important tool in drug discovery, providing a platform for preparing large compound libraries and enabling swift reaction screening over wide-ranging conditions. Recent advances in automated high-density, material-sparing HTE have necessitated the development of rapid analytics with sensitivity and resolution sufficient to identify products and/or assess reaction performance in

  高通量实验（HTE）已成为药物发现中的重要工具，它为制备大型化合物库提供了平台，并能够在广泛的条件下进行快速反应筛选。自动化的高密度，节省材料的HTE的最新进展，使得必须开发具有足够灵敏度和分辨率的快速分析方法，以便能够及时，丰富的数据来识别产品和/或评估反应性能。超通量（UT）读取器平台与声滴喷射-开放端口接口质谱法（ADE-OPI-MS）的结合提供了必需的速度和灵敏度。在此，我们报道了ADE-OPI-MS在HTE中在平行药物化学和反应筛选领域的应用。
• SUBSTITUTED 2-MERCAPTO-3-AMINOPYRIDINES AS KCNQ2/3 MODULATORS
  申请人：Kühnert Sven

  公开号：US20100234428A1

  公开（公告）日：2010-09-16

  The invention relates to substituted 2-mercapto-3-aminopyridines, methods for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

  这项发明涉及取代的2-巯基-3-氨基吡啶，其制备方法，含有这些化合物的药物以及利用这些化合物制备药物。